GSK Investigational Site
Stockbridge, Georgia 30281
We've found
1 trials
at this facility
Respiratory Syncytial Virus Infections Clinical Trial
Updated: 12/31/1969
A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials